Patiromer for hyperkalemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Mar 2023: Trial registered, NCT05766839
  2. 6 Apr 2025: Trial started, NCT05766839

The trials

NCT05766839: Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels

State
Under way
Phase
Phase 2
People
36 planned
Started
6 Apr 2025
Primary completion
1 Dec 2029
Arms
Patiromer
Results
None posted
  1. 13 Mar 2023: Trial registered
  2. 6 Apr 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.